Trial in progress: A phase 2 multicenter study (IOV-LUN-202) of autologous tumor-infiltrating Lymphocyte (TIL) cell therapy (LN-145) in mNSCLC Meeting Abstract
| Authors: | Chesney, J. A.; Schoenfeld, A. J.; Wise-Draper, T.; Sukari, A.; He, K.; Graf Finckenstein, F.; Hari, P.; Jagasia, M.; Samakoglu, S.; Leighton-Swayze, A.; Chen, G.; Hong, Y. K. |
| Abstract Title: | Trial in progress: A phase 2 multicenter study (IOV-LUN-202) of autologous tumor-infiltrating Lymphocyte (TIL) cell therapy (LN-145) in mNSCLC |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S395 |
| End Page: | S396 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.682 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: EP08.01-110 -- Located within section named "EP08.01 Metastatic Non-Small Cell Lung Cancer - Immunotherapy" -- Accession Number: 159037928 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
